Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gilabert

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Sangre|January 1, 1975
[Fibrinolytic activity of human endometrium saline extract (author's transl)]J J Parrilla, J Aznar, A Estelles, et al.
Thrombosis Research|December 15, 1989
Aprotinin (trasylol) is a competitive inhibitor of activated protein CF España, A Estelles, J H Griffin, et al.
Sangre|January 1, 1975
[Assessment of amniotic fluid fibrinolytic activity (author's transl)]A Hernandez, J J Parrilla, J Aznar, et al.
Thrombosis and Haemostasis|June 30, 1989
Functional and immunologic protein S in normal pregnant women and in full-term newbornsJ A Fernández, A Estellés, J Gilabert, et al.
Thrombosis Research|February 1, 1988
Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptivesJ Gilabert, J A Fernandez, F España, et al.
Thrombosis and Haemostasis|April 30, 1976
Changes in human amniotic fluid fibrinolytic inhibitor levels during pregnancyJ Aznar, A Hernandez, J J Parrilla, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1993
A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standardF España, J Sanchez-Cuenca, C D Vera, et al.
Thrombosis and Haemostasis|June 28, 1990
Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatmentD Tabernero, F España, V Vicente, et al.
Thrombosis and Haemostasis|November 1, 1996
Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardationS Grancha, A Estellés, J Gilabert, et al.
Gynecologic and Obstetric Investigation|January 1, 1990
Clinical and haemostatic parameters in the HELLP syndrome: relevance of plasminogen activator inhibitorsJ Gilabert, A Estellés, F Ridocci, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Sangre|January 1, 1975
[Fibrinolytic activity of human endometrium saline extract (author's transl)]J J Parrilla, J Aznar, A Estelles, et al.
Thrombosis Research|December 15, 1989
Aprotinin (trasylol) is a competitive inhibitor of activated protein CF España, A Estelles, J H Griffin, et al.
Sangre|January 1, 1975
[Assessment of amniotic fluid fibrinolytic activity (author's transl)]A Hernandez, J J Parrilla, J Aznar, et al.
Thrombosis and Haemostasis|June 30, 1989
Functional and immunologic protein S in normal pregnant women and in full-term newbornsJ A Fernández, A Estellés, J Gilabert, et al.
Thrombosis Research|February 1, 1988
Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptivesJ Gilabert, J A Fernandez, F España, et al.
Thrombosis and Haemostasis|April 30, 1976
Changes in human amniotic fluid fibrinolytic inhibitor levels during pregnancyJ Aznar, A Hernandez, J J Parrilla, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1993
A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standardF España, J Sanchez-Cuenca, C D Vera, et al.
Thrombosis and Haemostasis|June 28, 1990
Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatmentD Tabernero, F España, V Vicente, et al.
Thrombosis and Haemostasis|November 1, 1996
Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardationS Grancha, A Estellés, J Gilabert, et al.
Gynecologic and Obstetric Investigation|January 1, 1990
Clinical and haemostatic parameters in the HELLP syndrome: relevance of plasminogen activator inhibitorsJ Gilabert, A Estellés, F Ridocci, et al.
Pageof 8